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INTRODUCTION
‘You can’t expect Joe Six-Pack to be Bob
Brook.’ That was an off-the-cuff remark
thrown into a heated debate about publicly
reported high-quality data at one of the
‘Pennyhill Park’ health policy annual events
hosted by the Commonwealth Fund and the
Nufﬁeld Trust.1 Robert H Brook, former dir-
ector of RAND Health, has been a colossus
in the ﬁeld of healthcare quality measure-
ment for over 30 years.2
The sentiment expressed in that remark
captures the essence of the dilemma of estab-
lishing a policy on the collection and use of
data to assess the quality of a healthcare
system. We need enough of the right kind of
data to draw reliable and valid conclusions
about the performance of a hospital or health
service, but the resulting analysis cannot be so
technically challenging as to overwhelm its
users, including the potential recipients of
care and managers of the health system. Most
chief executive ofﬁcers in the English
National Health Service (NHS) are not health
professionals, and vanishingly few are sophisti-
cated health services researchers. Attempts to
overcome this problem with less complex data
and messages may end up as simplistic and
misleading.
Meyer et al3 in this issue of the Journal,
express concern at the ‘sky-rocketing’ number
of quality measures that are now required for
accountability purposes in the US healthcare
system, and predict that they could easily
move over the next few years from the current
hundreds of metrics to thousands.
We compare their critique of the place of
quality measures in the US healthcare system
to the context of the NHS as it undergoes
fundamental redesign to its structures and
accountability mechanisms.
MONEY AND ACTIVITY VERSUS QUALITY:
A FALSE DICHOTOMY
In England, the NHS has been slower to
grasp the challenge of measuring quality.
Until recently, policy makers have been
content to pride themselves on having moved
to a position in which quality improvement is
a central goal of the system. Laudable
though this has been, the dangers of espous-
ing quality as a goal strategically without con-
sidering how to operationalise it properly
(including measurement) have been evident
in spectacular failures in standards of care
when the much more easily quantiﬁable
measures—money and activity—were the
true priority for managers of the system.4 5
This issue has persistently rankled with profes-
sional staff delivering front-line care. No matter
how often the language of quality and safety is
spoken by those assessing performance, the true
lingua franca of healthcare is ﬁnancial. Many
clinicians in Britain remain unshakeable in their
belief that what really matters to patients or
themselves is not the same as what inﬂuences
those running the service. The portrayal of this
as a difference in values further deepens the rift
in perceived perspectives. The dysfunction has
arguably been worsened by the NHS policy of
Payment by Results (PbR)6 introduced in 2003.
In most cases, this links payment to volume of
activity, although there are a growing number of
‘Best Practice Tariffs’ incorporating quality mea-
sures, such as rapid access to a CT scan for those
who have suffered a stroke.7 PbR has made clini-
cians aware of the way in which data derived
from patient records are linked to ﬁnancial
reward for their institutions. Meanwhile, the
absence of a comparable set of powerful data on
the quality of care provided—data that are uni-
versally believed and trusted—sustains this
divide between managerial and clinical cultures.
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NHS hospital organisations are now required to
produce a set of quality accounts together with their
ﬁnancial report, but the level of parity the board places
between them remains to be seen. The argument that
the business plan of a hospital and the quality plan
might be one and the same document can bring a
glimmer of enlightenment to even the most hardened
managerial traditionalist, but it has not yet translated to
a paradigm shift in the concept of accountability and
how performance is judged.
CLINICALLY CURATED VERSUS ADMINISTRATIVELY
DERIVED DATA
The successful development of widely accepted and
extensively used quality measures in the NHS has been
limited to particular ﬁelds of care. The Myocardial
Ischaemia National Audit Project (MINAP)8 is a promin-
ent example. All hospitals in England and Wales that
admit patients with acute coronary syndromes provide
data. This has allowed a rich and detailed description of
the quality of care in different centres and over time. It
has allowed services to be held to account for standards
set in the National Service Framework for coronary
heart disease.9 It has been embraced clinically and man-
agerially, and other initiatives involving rigorous collec-
tion of speciﬁed quality data in heart disease have
enabled public reporting of service performance as well
as non-emotive public debate about variations in stan-
dards of care.10 However, the number of truly clinically
led national data collection systems is limited and
restricted to major conditions.11
By contrast, the derivation and use of a high-level
summary index of quality, such as the Hospital
Standardised Mortality Ratio, from routinely available
data has been dogged by controversy.12 Views have been
polarised between those who point to the measure’s
indispensability in uncovering hitherto hidden problems
in a service, and those who consider that they should
defend, to the hilt, reputations from a statistic that they
consider completely ﬂawed. The time-honoured middle-
ground position, that such a measure is only a starting
point for further investigation, has held little sway in the
heat of recent public discourse about measuring the
quality of a hospital’s services.
The main source of NHS information on hospital
patients, from which this and similar summary measures
of quality are derived is Hospital Episode Statistics. This
system has been criticised for substandard data
quality.13 14 The quality of routinely available data is not
a good reﬂection of clinical practice, and clinicians show
little interest in it. Indeed, in one study, only 8% of clini-
cians participated in the validation of clinical coded
data.13 Poor quality data lead to lack of conﬁdence in
them, and ultimately rejection of ﬁndings derived from
them. A project undertaken by the Royal College of
Physicians of London and the Department of Health in
England sought to secure greater clinical engagement in
routinely available data systems with the aim of improv-
ing their quality, use and relevance.15 It found that clini-
cians were wary that such data might be used for
judging them because the scope did not encompass out-
patients where much of their work was based, and
because modern care is delivered by teams so that
consultant-speciﬁc quality measures are not reliable.16
The strength of clinical specialty or condition-speciﬁc
systems, like MINAP, that capture quality measures is that
they are mainly clinically curated. Thus, the data selected
for inclusion are relevant and outcome orientated;
capture of data is comprehensive, and they are less dis-
puted by outliers as often happens with data gathered
under management auspices. When the data standards
have been set by your peers, it is harder to wave away, or
excuse, inconvenient statistics about your service.
NHS SYSTEM REFORMS REQUIRE GOOD DATA
A commitment to making quality and safety the ‘organis-
ing principle’ of the NHS was made by Prime Minister
Brown’s Government in its White Paper, High Quality
Care for All.17 Background work for this strategy found
that the highest performing clinical teams used quality
data routinely.18 In one of the leading hospitals in the
USA, on one quality-ranking scheme, the approach to
gaining full clinical engagement has been to make the use
of data a credible ‘scientiﬁc’ endeavour rather than an
activity required by management (Pronovost P; personal
communication). Creating a clinical culture in which such
‘dataphilia’ among clinicians in the NHS is commonplace
is a major challenge, but if it could be done, there would
be major gains. The reasons why it is not so, currently, are
again deep seated and include: limited exposure in under-
graduate and postgraduate medical education pro-
grammes to quality-of-care concepts; a lack of conﬁdence
in the validity of routine data; the absence of professional
leadership in embedding it as a core component of good
clinical practice; and the low value of health services
research (using such data) in career advancement com-
pared with clinical and molecular research.
Meyer et al3 call for greater selectivity and for counting
things that matter. They argue for metrics that serve the
needs of end users (patient, families, payers) for
accountability of performance and for judging quality
and value while achieving parsimony in the number and
type chosen. It is important that there are such system-
wide indicators that provide insight into the quality and
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safety of care being provided, whether that ‘system’ is
the whole provision of care in a country or that deliv-
ered in a hospital or primary care service. However, it is
equally important that front-line clinical teams also have
data that they use to compare themselves with the best,
and to assess whether they are improving over time.
Those data will encompass many more measures of
quality and will relate closely to the speciﬁc context of
the area of care. Health policy makers are not always
sure whether to encourage clinicians to have as much
data as they feel they need in order to evaluate their ser-
vices. There is also uncertainty on how much of such
data should be extracted for management oversight, or
rolled into summary measures for monitoring system
performance. Moreover, there is a paucity of good meth-
odological work on how best to aggregate information
from a diversity of quality measures.
Major reforms to the NHS in England, now being
implemented, create an urgent need for good data in
two areas. First, with plans to devolve most decisions
about the planning and funding of care for populations
to local level in entities called Clinical Commissioning
Groups, the previous management bodies that con-
trolled these functions will disappear. Accountability for
the delivery of provider-contractual requirements, for
assessing return on public investments and for seeking
equity of care, will only be possible through data.
Second, the new system relies on choice by patients.
This too will require data.
The coalition government that came to power in 2010 set
out these reforms in its White Paper, Equity and Excellence:
liberating the NHS.19 This acknowledges the importance of
data on quality and sets out proposals for an NHS
Outcomes Framework covering ﬁve outcome domains (pre-
mature death, quality of life for chronic disease, recovery
from illness or injury, experience of care, safety), and a com-
prehensive suite of standards to support the framework.
However, the focus on outcome over process metrics,20 the
centrally deﬁned nature of the framework, and the lack of
widespread clinical consensus have led to criticism. A
library of some 150 standards is to be developed over the
next 5 years by the National Institute for Health and
Clinical Excellence, which may generate a more clinically
plausible, if not lean, set of standards.21
After a series of horror stories about staff attitudes
towards care, often when looking after elderly or vulner-
able patients,22 the measurement of patient experience
has gained a renewed focus within the NHS. Although
there are existing detailed national random surveys of
experience, asking a broad array of questions, the
English NHS is now pushing the notion of a simple,
single question about experience borrowed from a con-
sumer notion of customer service: would you recom-
mend to family and friends the service you have
received? However, in this drive towards simplicity, there
have been further voices of discontent. In reviewing the
approach, the Picker Institute suggested that many
people thought of asking a cancer survivor whether they
would recommend their service—a potentially insensi-
tive question to ask23—demonstrating that simplicity
alone is not always acceptable.
Data that measure the quality of healthcare are
needed for accountability, consumer choice and quality
improvement. In their development, the fundamental
tension of performance measurement comes to the fore.
Metrics must be acceptable to clinicians, collectable
from management systems and understandable by the
public. A simple triad that is hard to reconcile.
CONCLUSION
The longstanding orientation of the US healthcare
system towards billing, claims documentation, accredit-
ation of providers, scrutiny by payers, and public report-
ing of outcomes has ensured a commitment to the
development of data systems to measure clinical service
performance. As Meyer et al3 put it: ‘Our investments in
required quality measures have served us well.’ They
rightly argue for careful selection from among the large
volume of available quality measures, as well as for
keeping the numbers used down to manageable levels.
The NHS is in a very different place. For the ﬁrst
50 years of its existence, quality was implied but not
made explicit. When, in the late 1990s, frameworks and
programmes were created to promote higher quality and
safer care, measurement trailed behind. As a result, the
things that could be measured (ie, money and activity)
were the focus of management. When major failures in
standards of care did occur, investigators pointed out
that the quality rhetoric did not match the realities of
patient care. The NHS has lacked a set of clinical data
that are comprehensive, trusted and that provide deep
insights into the quality and safety of care. The culture
of care does not currently embrace the centrality of data
to a health professional’s work. As a priority, clinicians
need access to good data that give them insights into the
quality and safety of care that they are giving to their
patients. This will have to be detailed and speciﬁc to the
context of their ﬁeld of care. Getting there will mean a
transformation of culture and attitudes that in turn will
require strong leadership.
The quality of NHS administratively derived data
remains patchy. Ironically, databases established and run
by clinical groups have been very successful, overcoming
problems of clinical engagement, trust in the informa-
tion they provide and intelligibility. However, they have
remained somewhat apart in visions of the future, as the
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focus has shifted to deriving measures from the elec-
tronic health record. Clarity of strategic thinking is
required to sustain the best of the clinical databases,
engage clinicians in strengthening routinely available
administrative data, and to design the means to translate
digital records into data that speak the language of
quality.
Reforms to the NHS in England, currently underway,
that involve devolution of budgets to local clinical groups,
and a stronger role for regulators, cannot succeed in
establishing accountability for the assurance of the
quality and safety of care, nor the stewardship of very
large amounts of tax-payers’ money, without credible
data. Ambitious plans are in place to generate measures
of quality. Ultimately, this will lead into the same territory
as Meyer et al3 have described. The NHS will have to
accept, in system-wide monitoring, the modern maxim
that ‘less is more’.
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